share_log

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga ·  Mar 11 17:34

Gainers

  • CareMax (NASDAQ:CMAX) stock increased by 16.9% to $8.0 during Monday's after-market session. The market value of their outstanding shares is at $29.9 million.
  • Burning Rock Biotech (NASDAQ:BNR) stock moved upwards by 12.34% to $0.91. The market value of their outstanding shares is at $93.4 million.
  • LifeMD (NASDAQ:LFMD) shares increased by 11.19% to $8.84. The market value of their outstanding shares is at $346.5 million. The company's, Q4 earnings came out today.
  • SCWorx (NASDAQ:WORX) stock increased by 9.13% to $2.03. The market value of their outstanding shares is at $2.4 million.
  • Innate Pharma (NASDAQ:IPHA) shares rose 8.79% to $2.66. The market value of their outstanding shares is at $215.0 million.
  • Clearside Biomedical (NASDAQ:CLSD) shares rose 8.41% to $2.19. The company's market cap stands at $163.6 million.

Losers

  • CytomX Therapeutics (NASDAQ:CTMX) stock declined by 22.3% to $1.95 during Monday's after-market session. The market value of their outstanding shares is at $130.6 million. As per the news, the Q4 earnings report came out today.
  • ACADIA Pharmaceuticals (NASDAQ:ACAD) stock declined by 15.05% to $20.5. The company's market cap stands at $3.3 billion.
  • PaxMedica (NASDAQ:PXMD) stock fell 12.4% to $0.65. The company's market cap stands at $2.9 million.
  • Cognition Therapeutics (NASDAQ:CGTX) stock decreased by 10.16% to $1.77. The company's market cap stands at $56.8 million.
  • Ocular Therapeutix (NASDAQ:OCUL) stock decreased by 9.05% to $8.85. The company's market cap stands at $1.0 billion. The company's, Q4 earnings came out today.
  • Atreca (NASDAQ:BCEL) shares decreased by 8.83% to $0.19. The market value of their outstanding shares is at $7.6 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment